List view / Grid view
The Competition and Markets Authority fines Advanz and two others…
The Competition and Markets Authority fines Advanz and two others for hiking prices of liothyronine tablets by 1,110 percent in eight years.
The UK’s Competition and Markets Authority (CMA) has fined four…
The UK’s Competition and Markets Authority (CMA) has fined four companies in because of anti-competitive practices in the supply of nortriptyline.
The Competition and Markets Authority (CMA) announced the EU Court…
The Competition and Markets Authority (CMA) announced the EU Court of Justice agreed that GSK had paid to delay other competitors entering the UK paroxetine generics market.
The CMA alleges that Aspen broke competition law, prompting the…
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
